|Day Low/High||92.17 / 94.42|
|52 Wk Low/High||47.71 / 97.80|
Questcor Pharmaceuticals was a winner within the drugs industry, rising 42 cents (1.6%) to $26.83 on light volume.
Questcor Pharmaceuticals was a leading decliner within the health care sector, falling $2.27 (-8.1%) to $25.90 on light volume.
Questcor Pharmaceuticals was a winner within the drugs industry, rising 34 cents (1.3%) to $25.70 on light volume.
Insiders usually buy their own shares for one reason: They think the stock is a bargain and has tremendous upside.
The top 10 open-market insider purchases and sales filed at the SEC Tuesday.
Questcor Pharmaceuticals was a winner within the health care sector, rising 82 cents (3.4%) to $24.96 on light volume.
Lieff Cabraser Heimann & Bernstein, LLP reminds investors of the November 26, 2012 deadline to move for appointment as lead plaintiff in the securities class litigation against Questcor Pharmaceuticals,...
The ex-dividend date for Questcor Pharmaceuticals (Nasdaq:QCOR) is Monday, October 29, 2012. Owners of shares as of market close today will be eligible for a dividend of 20 cents per share. At a price of $26.26 as of 9:30 a.m., the dividend yield is 3.1%.
Questcor Pharmaceuticals (Nasdaq:QCOR) has been downgraded by TheStreet Ratings from from a buy to hold.
Ryan & Maniskas, LLP ( www.rmclasslaw.
The law firm of Lieff Cabraser Heimann & Bernstein, LLP announces that class action lawsuits have been brought on behalf of all persons who purchased or otherwise acquired the securities of Questcor...
Thanks to European and Chinese inaction, American companies have been able to adjust and profit.
Questcor Pharmaceuticals was a winner within the health care sector, rising 89 cents (4.6%) to $20.29 on average volume.
Unusual volume can be a major signal that hedge funds and momentum traders are piling into a stock ahead of a catalyst.
Wolf Haldenstein Adler Freeman & Herz LLP has filed a class action lawsuit in the United States District Court, Central District of California, on behalf of all persons who purchased the common stock of Questcor...
Newman Ferrara LLP announces that a class action lawsuit has been filed in the Central District of California against Questcor Pharmaceuticals, Inc.
Ryan & Maniskas, LLP ( www.rmclasslaw.
Often when above-average volume moves into an equity, it precedes a large spike in volatility.
Shareholder Rights Law Firm Johnson & Weaver, LLP has commenced an investigation into whether certain officers and directors of Questcor Pharmaceuticals Inc.
Blyth's Catch-22; Questcor Crumbles; Musk's Macho Mess; RIM's Terrible Timing; Intel Bugs Buddy.
Questcor Pharmaceuticals was a leading decliner within the drugs industry, falling 41 cents (-2.3%) to $17.83 on average volume.
Securities lawyers at Goldfarb LLP are investigating alleged violations of shareholder protection laws by officers and directors of Questor Pharmaceuticals.
Former United States Securities and Exchange Commission attorney Willie Briscoe, founder of The Briscoe Law Firm, PLLC, and the securities litigation firm of Powers Taylor, LLP announce that the firms are...
Former Attorney General of Louisiana, Charles C. Foti, Jr.
The major U.S. equity averages finish with slight losses as Europe continues to struggle with how to deal with its debt problems.
Tony Pelz shows investors how to monitor unusual options trades to manage risk.
Questcor Pharmaceuticals (Nasdaq:QCOR) is trading at unusually high volume Thursday with 11 million shares changing hands. It is currently at 4.3 times its average daily volume and trading up $3.52 (+13.4%).
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.